Mode
Text Size
Log in / Sign up

Systematic review describes polysaccharide mechanisms and structure-activity relationships for anti-cancer effectsReview explores how natural polysaccharides may work against cancer in lab studies

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Preclinical review describes polysaccharide anti-cancer mechanisms; clinical efficacy and safety are not established.

A systematic review article synthesized existing research on natural polysaccharides and their potential anti-cancer properties. The review summarized preclinical and cell-based studies, describing mechanisms of action but did not report on a specific clinical population, sample size, comparator, or primary outcome. No clinical trial data, statistical measures of effect, or safety outcomes from human studies were included.

The main findings from the reviewed literature indicate polysaccharides may exert synergistic anti-cancer effects through multi-target, multi-pathway mechanisms. These include the induction of immune cell polarization and tumor cell apoptosis, inhibition of tumor cell migration and angiogenesis, and modulation of key signaling pathways such as P53, NF-κB, and Wnt/β-catenin. The review also reported that polysaccharides with specific structural features—like certain monosaccharide compositions, optimal molecular weights, β-glycosidic linkages, triple-helix conformations, or chemical modifications—exhibit enhanced biological and anti-tumor activities in preclinical models.

Safety and tolerability data from human studies were not reported. The authors of the review identified key limitations in the current evidence base, noting that future efforts should focus on elucidating structure-activity relationships, developing targeted delivery systems to improve bioavailability and tumor specificity, and advancing large-scale, multi-center, long-term clinical trials. The practice relevance is restrained; this review summarizes mechanistic and preclinical findings only. It serves as a foundation for future research but does not provide evidence to support current clinical use, as clinical efficacy and safety profiles remain unestablished.

Scientists reviewed existing research on natural polysaccharides, which are complex sugars found in plants, fungi, and other sources. The review compiled findings from laboratory and animal studies to understand how these compounds might work against cancer. The goal was to map out the potential mechanisms and identify which structural features of the molecules might be most important for their activity.

The review found that, in these early studies, polysaccharides appear to work in several ways. They might help activate certain immune cells, trigger cancer cell death, and prevent tumors from creating new blood vessels or spreading. The research also suggests that specific characteristics—like the sugar's size, shape, and chemical bonds—can influence how well it works in lab tests.

It is crucial to understand that this is a review of preclinical research. This means the findings come from test tubes, cells, and animal models, not from human clinical trials. The report does not include any data on how effective or safe these compounds are for people with cancer. The authors themselves note that large, long-term human trials are needed to see if these lab findings translate into real, safe treatments. For now, this research helps guide future scientific questions but does not represent a proven therapy.

What this means for you:
Lab research suggests natural polysaccharides may have anti-cancer properties, but human safety and effectiveness are not yet known.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Cancer remains a formidable global health challenge, characterized by alarmingly high incidence and mortality rates. Traditional clinical therapies are often accompanied by obvious toxicity and side effects, highlighting the urgent need to develop safer and more effective therapeutic alternatives. In recent years, polysaccharides have emerged as promising candidates for anti-tumor drugs due to their wide sources, high biocompatibility and low toxicity. This review summarizes recent advances in anti-tumor effects of polysaccharides, covering their underlying mechanisms, key signaling pathways and selective toxicity characteristics. Polysaccharides exert synergistic anti-cancer effects through multi-target, multi-pathway mechanisms, including the induction of immune cell polarization and tumor cell apoptosis, inhibition of tumor cell migration and angiogenesis, and modulation of key signaling pathways such as P53, NF-κB, and Wnt/β-catenin. Among these, polysaccharides with specific monosaccharide compositions, optimal molecular weights, β-glycosidic linkages, triple-helix conformations, or those that are chemically modified, exhibit enhanced biological and anti-tumor activities. Future efforts should focus on elucidating structure-activity relationships, developing targeted delivery systems to improve bioavailability and tumor specificity, and advancing large-scale, multi-center, long-term clinical trials to support the development of safe and effective polysaccharide-based anti-cancer therapeutics.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.